Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc KHTRF


Primary Symbol: T.GUD

Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

Bullboard (TSX:GUD)

View:
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
Post by MrMugsyon Oct 07, 2022 8:08am

New sub - 500K bb

Both ... a new submission  and ~ 500K in buybacks
206
Discussion
Comment by longrun86on Oct 06, 2022 12:55am

RE:RE:25k shares jump to 316k at 11:15 osh

The past few months have been pretty boring but I've been ok with it. I would like to think that at these prices the shares are going to stronger hands. The Company itself is likely one of the ...more  
196
Discussion
Comment by EbbFlow88on Oct 05, 2022 3:03pm

RE:25k shares jump to 316k at 11:15 osh

This is buybacks, new positions and additions to existing positions. I have added at 5.35 personally this week. Obviously, there are also sellers here but IMO they're going to stronger hands ...more  
147
Discussion
Post by GoldenInvestoron Oct 03, 2022 11:18am

25k shares jump to 316k at 11:15 osh

Buybacks? new positions? nice big jump in volume!
199
Discussion
Comment by EbbFlow88on Sep 29, 2022 1:46pm

RE:Let the buybacks continue

September should be a good proxy to see how aggressive they will be for buybacks and whether there may be something else in the pipeline. The average price this month has been around $5.50 which is a ...more  
211
Discussion
Post by EbbFlow88on Sep 29, 2022 1:22pm

Let the buybacks continue

This market turmoil will be great for another 8M share buyback this year. Let the accumulation continue...
162
Discussion
Post by MrMugsyon Sep 28, 2022 4:51pm

Love the ENDO drama !

Seven state attorneys general, including Pennsylvania AG Josh Shapiro, and a federal bankruptcy overseer appointed by the court, are objecting to the $94 million paid in pre-bankruptcy bonuses to top ...more  
225
Post by GoldenInvestoron Sep 28, 2022 2:40pm

Our Alzheimer’s drug already on market

Vs biogen still had some stages to clear. either way more products aiming to fight Alzheimer's.  Increased attention for our product & products as alternatives 
119
Post by GoldenInvestoron Sep 28, 2022 2:24pm

EISAI is a partner on another cancer drug (Lenvima) of ours

and the maker of this new Alzheimer drug being produced by BIOGEN. BIOGEN and other related parties soaring today.
119
Post by Chianchinon Sep 28, 2022 1:44pm

The end of GUD

https://www.barrons.com/articles/alzheimers-drug-success-stock-51664378083?mod=hp_LEAD_3
158
Comment by MrMugsyon Sep 23, 2022 3:11pm

RE:RE:RE:RE:RE:Revenue comparison 10 years later

Absolutely adverse at these prices ... they have always been gungho to go to market "only" at higher valuations.  Therefore the next one would need to be over $10. But - value and ...more  
248
Discussion
Comment by longrun86on Sep 23, 2022 1:15pm

RE:RE:RE:RE:Revenue comparison 10 years later

The shelf prospectus provides for optionality and I see it being wise to keep it going. Management and the Board are likely averse to raising equity at these prices but the debt possibility of the ...more  
157
Discussion
Comment by MrMugsyon Sep 23, 2022 1:00pm

RE:RE:RE:Revenue comparison 10 years later

Note that the shelf prospectus should expire in early 2023 (Jan 23 2023 ?) I believe this was positioned to take advantage of ATE's 346 chronic drug in South America - which didn't happen for ...more  
171
Discussion
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities